OTC Markets OTCPK - Delayed Quote USD

MedMira Inc. (MMIRF)

Compare

0.0207

0.0000

(0.00%)

At close: April 15 at 4:00:00 PM EDT

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for MMIRF

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

MedMira Inc. (MMIRF)

Recent News: MMIRF

MedMira Second Quarter 2025 Earnings: CA$0.002 loss per share (vs CA$0.001 loss in 2Q 2024)

MedMira Reports Second Quarter Results FY2025

MedMira Announces Partnership with MediGroup Physician Services in the United States

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test

MedMira Reports First Quarter Results FY2025

Health Canada approves MedMira’s rapid test for HIV and syphilis

TSX Venture Exchange Stock Maintenance Bulletins

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV